Clarithromycin

Clarithromycin has been studied in 4 papers since 2005: 3 trials and 1 observational study in people; 2 in the past year. The newest paper, Mar 27, 2026: “Long-term Effect of Helicobacter pylori Eradication on Risk Factors for Cardiovascular Disease - Is there a Connection?”.

Intervention

4 papers study it6 more mention itUpdated

PubChemChEBIMeSH

See all 10 papers on clarithromycin

At a glance

42 trials, none about aging, 22 with no results posted.

Cells, worms or flies, mice and humans: nothing yet.
  • 42 trials, none about aging, 22 with no results posted
  • Human trial3
  • Humans1

Who is developing clarithromycin?

3 companies: Janssen Pharmaceutical, Reistone Biopharma Company and Pfizer.

Companies
  • Janssen PharmaceuticalPhase 2/3treatment-refractory mycobacterium avium complex-lung disease
  • Reistone Biopharma CompanyPhase 1non-cystic fibrosis bronchiectasis、chronic sinusitis without nasal polyps、chronic obstructive pulmonary disease
  • PfizerPhase 1

Trial sponsors

Latest

Dec 2025: 0Jan 2026: 1Feb 2026: 0Mar 2026: 2Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 03 papers in 12 months